Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia: a Multicenter Randomized, Double Blind, Placebo Controlled, Clinical Trial

NCT06722586 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06722586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06722586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia: a Multicenter Randomized, Double Blind, Placebo Controlled, Clinical Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 7, 2025
Completion date
December 31, 2027
Enrollment
84 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid (apl)-positive, thrombocytopaenia